SSRIs and Misconceptions

The conversation delves into the complexities surrounding the prescription of SSRIs, emphasizing their continued use as a first-line treatment for major depressive disorder and anxiety. Mikhail highlights the stigma and misinformation that often clouds public perception, pointing out that even well-known health influencers can misrepresent how these medications function. Despite the ongoing debates about their efficacy, the positive outcomes observed in patients cannot be overlooked.